COVID-19 Impact on World-Wide Pharma Companies

The COVID-19 pandemic influenced the year 2020, and Pharma was not only at the vanguard of attempts to combat the virus, but it was also vulnerable to the impacts of lockdowns. The hunt for a vaccine displaced existing capacity and clinical development programs, but it sparked unprecedented industrial collaboration. It also showcased the industry's remarkable adaptability and innovation. Long-term effects of the COVID-19 pandemic on the pharmaceutical sector in both global and local levels could include slowed industry growth, delays in approvals, and self-sufficiency in the pharm-production supply chain, as well as trend changes in health-market product consumption and ethical crises.